These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 15753008)

  • 1. The epidemiology of human papillomavirus infections.
    Baseman JG; Koutsky LA
    J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
    Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
    Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
    Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and epidemiology of HPV infection and cervical cancer.
    Castellsagué X
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus: the burden of infection.
    Wiley D; Masongsong E
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital human papillomavirus infection.
    Dunne EF; Markowitz LE
    Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus: often harmless but in some cases carcinogenic.
    Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.
    Nielsen A; Kjaer SK; Munk C; Iftner T
    Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines.
    Einstein MH
    Cancer Immunol Immunother; 2008 Apr; 57(4):443-51. PubMed ID: 18157723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clearance, persistence and recurrence of HPV infection].
    Denis F; Hanz S; Alain S
    Gynecol Obstet Fertil; 2008 Apr; 36(4):430-40. PubMed ID: 18417407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M
    Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
    Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
    J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy.
    Broccolo F; Chiari S; Piana A; Castiglia P; Dell'Anna T; Garcia-Parra R; Maneo A; Villa A; Leone EB; Perego P; Maida A; Mangioni C; Cocuzza CE
    J Med Virol; 2009 Feb; 81(2):278-87. PubMed ID: 19107971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.